gemcitabin fresenius kabi 200 mg
fresenius kabi norge as - halden - gemcitabinhydroklorid - pulver til infusjonsvæske, oppløsning - 200 mg
gemcitabin fresenius kabi 1 g
fresenius kabi norge as - halden - gemcitabinhydroklorid - pulver til infusjonsvæske, oppløsning - 1 g
gemcitabin fresenius kabi 2 g
fresenius kabi norge as - halden - gemcitabinhydroklorid - pulver til infusjonsvæske, oppløsning - 2 g
clobex 500 mikrog/ g
2care4 aps - klobetasolpropionat - sjampo - 500 mikrog/ g
bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - lungesykdom, kronisk obstruktiv - formoterol og glycopyrronium bromide - bevespi aerosphere er angitt som en vedlikehold bronkodilaterende behandling for å lindre symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kols).
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiske midler - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
bevespi aerosphere 7.2 mikrog / 5 mikrog
orifarm as - glykopyrroniumbromid / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 7.2 mikrog / 5 mikrog